Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04110314 · ClinicalTrials.gov registry record · NA
Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2
A NA study, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- NA
- Development phase
- 430,636
- Enrollment target
NCT04110314 is a NA study that has completed, run by University of California, Los Angeles. The registered enrollment target is 430,636 participants.
The verdict
NCT04110314, a NA study, has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- NA
- Development phase
- 430,636 participants
- Enrollment target
Study Summary
This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rates remain low. The investigators will assess the effectiveness of message-framing (gain-framed, loss-framed messages, no messages), as well as the effectiveness of a pre-commitment prompt (pre-commitment prompt, no prompt) asking about a patient's intention to get the influenza vaccination, using a 3 x 2 factorial design.
Interventions
- BEHAVIORAL Portal Reminders for Influenza Vaccination: Gain-framed
- BEHAVIORAL Portal Reminders for Influenza Vaccination: Loss-framed
- BEHAVIORAL Pre-commitment prompt
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 430,636 participants |
| Start Date | 2019-10-18 |
| Est. Completion | 2020-04-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04110314
The ClinicalTrials.gov registry entry for NCT04110314 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 430,636 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Portal Reminders for Influenza Vaccination: Gain-framed is the first listed.
NCT04110314 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04110314 about?
NCT04110314 is a clinical study titled "Patient Portal Reminder/Recall for Influenza Vaccination in a Health System- RCT 2". This trial is taking place in Los Angeles, CA among patients from primary care practices within the UCLA Health System. Despite the Advisory Committee on Immunization Practices (ACIP) recommendation in 2010 that all people above 6 months of age should receive an annual flu vaccine, vaccination rate...
What is the current status of trial NCT04110314?
This trial is currently completed. It is a NA study. The enrollment target is 430,636 participants. The study started on 2019-10-18. Estimated completion is 2020-04-01.
What interventions are being tested in trial NCT04110314?
The interventions under investigation include: Portal Reminders for Influenza Vaccination: Gain-framed (BEHAVIORAL), Portal Reminders for Influenza Vaccination: Loss-framed (BEHAVIORAL), Pre-commitment prompt (BEHAVIORAL).
Who is sponsoring clinical trial NCT04110314?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.